My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lonquex



Teva B.V.EU/1/13/856/001-002

Main Information

Trade NameLonquex
Active SubstancesXm22 drug substance lipegfilgrastim
Dosage FormSolution for injection in pre-filled syringe
Licence HolderTeva B.V.
Licence NumberEU/1/13/856/001-002

Group Information

ATC CodeL03AA Colony stimulating factors
L03AA14 lipegfilgrastim

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal products on restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print